RIL
CGON icon

Rothschild Investment LLC’s CG Oncology CGON Stock Holding History

Rothschild Investment LLC’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.82K Buy
110
+8
+8% +$523 ﹤0.01% 2027
2026
Q1 		$6.9K Buy
102
+12
+13% +$680 ﹤0.01% 1887
2025
Q4 		$3.74K Hold
90
– – ﹤0.01% 2043
2025
Q3 		$3.63K Sell
90
-20
-18% -$581 ﹤0.01% 1861
2025
Q2 		$2.86K Buy
110
+65
+144% +$1.57K ﹤0.01% 1820
2025
Q1 		$1.1K Buy
45
+20
+80% +$563 ﹤0.01% 2283
2024
Q4 		$717 Hold
25
– – ﹤0.01% 2396
2024
Q3 		$943 Buy
25
+15
+150% +$526 ﹤0.01% 2205
2024
Q2 		$316 Buy
+10
New +$347 ﹤0.01% 2269

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Rothschild Investment LLC's CGON Position: Q2 2026 in Review

Rothschild Investment LLC increased its CG Oncology (CGON) stake by 7.8% in Q2 2026, buying an estimated $523 and bringing the position to 110 shares worth $7.82K. The position accounts for ﹤0.01% of the portfolio, ranked #2027.

Rothschild Investment LLC first reported a position in CGON in Q2 2024 and has held it in 9 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Rothschild Investment LLC held 110 shares of CG Oncology worth $7.82K as of Q2 2026.
  • Rothschild Investment LLC bought 8 CG Oncology shares in Q2 2026, an estimated $523.
  • CG Oncology made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2027 holding.
  • Rothschild Investment LLC first reported a position in CG Oncology in Q2 2024 and has held it in 9 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.